CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.900
-0.080 (-8.16%)
At close: Apr 28, 2026, 4:00 PM EDT
0.900
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:48 PM EDT
CytoMed Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for CytoMed Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for CytoMed Therapeutics.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +455.55% | Oct 10, 2024 |
| Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +455.55% | Jun 11, 2024 |
| Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +455.55% | Dec 4, 2023 |
| Benchmark | Benchmark | Buy Initiates $5 | Buy | Initiates | $5 | +455.55% | Jul 21, 2023 |
Financial Forecast
Revenue This Year
n/a
from 860.85K
Revenue Next Year
n/a
EPS This Year
n/a
from -0.34
EPS Next Year
n/a
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.